Civitas Therapeutics was a privately held biopharmaceutical company founded in 2009 (Chelsea/Cambridge, Massachusetts) that developed inhaled therapeutics using the proprietary ARCUS dry-powder pulmonary delivery platform.
company life-sciences parkinsons-disease pharmaceuticals drug-development apis-json acquired biopharmaceutical inhalation-therapy
-
Updated
Aug 2, 2026